Literature DB >> 31106008

Nonsurgical Options for the Treatment of Basal Cell Carcinoma.

John Paoli1,2, Johan Dahlén Gyllencreutz3, Julia Fougelberg1,2, Eva Johansson Backman1,2, Maja Modin1,2, Sam Polesie1,2, Oscar Zaar1,2.   

Abstract

OBJECTIVES: The aim of this review article is to summarize the effectiveness, potential adverse events, and indications of the main nonsurgical treatment alternatives for basal cell carcinoma.
METHODS: An extensive literature review was carried out. The most relevant articles were discussed and selected by the authors in order to provide a brief but evidence-based overview of the most common nonsurgical methods used for treating basal cell carcinoma.
RESULTS: Although surgery and Mohs micrographic surgery are often considered the optimal treatment options for basal cell carcinoma, these tumors can also be treated successfully with destructive techniques (eg, curettage alone, cryosurgery, or electrodesiccation), photodynamic therapy, topical drugs (eg, 5-fluorouracil, imiquimod, or ingenol mebutate), radiotherapy, or hedgehog pathway inhibitors. When choosing between these alternatives, physicians must take into consideration the tumor's size, location, and histopathological subtype. Special care should be taken when treating recurrent tumors. Furthermore, physician experience is of great importance when using destructive techniques. Finally, patient preference, potential adverse events, and cosmetic outcome should also be considered.
CONCLUSIONS: Dermatologists and physicians treating basal cell carcinoma should have knowledge of and experience with the large arsenal of therapeutic alternatives available for the successful, safe, and individualized management of patients with basal cell carcinoma.

Entities:  

Keywords:  basal cell carcinoma; destructive therapy; hedgehog inhibitors; radiotherapy; topical drugs

Year:  2019        PMID: 31106008      PMCID: PMC6502306          DOI: 10.5826/dpc.0902a01

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


  72 in total

1.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study.

Authors:  A M Soler; T Warloe; J Tausjø; A Berner
Journal:  Acta Derm Venereol       Date:  1999-05       Impact factor: 4.437

2.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.

Authors:  I Wang; N Bendsoe; C A Klinteberg; A M Enejder; S Andersson-Engels; S Svanberg; K Svanberg
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

3.  Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues.

Authors:  I S COPPER
Journal:  N Engl J Med       Date:  1963-04-04       Impact factor: 91.245

4.  Treatment of basal cell carcinoma by electrodesiccation and curettage.

Authors:  G S WILLIAMSON; R JACKSON
Journal:  Can Med Assoc J       Date:  1962-05-12       Impact factor: 8.262

5.  The treatment of basal cell carcinoma by curettage.

Authors:  R D SWEET
Journal:  Br J Dermatol       Date:  1963-04       Impact factor: 9.302

6.  Curettage and electrodesiccation in the treatment of skin cancer.

Authors:  J M KNOX; T W LYLES; E M SHAPIRO; R D MARTIN
Journal:  Arch Dermatol       Date:  1960-08

7.  Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers.

Authors:  Peter Nordin; Bo Stenquist
Journal:  J Laryngol Otol       Date:  2002-11       Impact factor: 1.469

8.  Surface microscopy of pigmented basal cell carcinoma.

Authors:  S W Menzies; K Westerhoff; H Rabinovitz; A W Kopf; W H McCarthy; B Katz
Journal:  Arch Dermatol       Date:  2000-08

9.  Cryosurgery for skin cancer: 30-year experience and cure rates.

Authors:  Emanuel G Kuflik
Journal:  Dermatol Surg       Date:  2004-02       Impact factor: 3.398

Review 10.  Interventions for basal cell carcinoma of the skin: systematic review.

Authors:  Fiona Bath-Hextall; Jan Bong; William Perkins; Hywel Williams
Journal:  BMJ       Date:  2004-09-13
View more
  4 in total

1.  Superficial Basal Cell Carcinoma of the Face Successfully Treated with Ingenol Mebutate 0.05% Gel: Case Report and a Review of the Literature.

Authors:  Theodore Rosen; Kami Lowery
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 2.  Basal Cell Carcinoma Surgery in general practice: Is there a role for the local General Practitioner?

Authors:  S H Keah; S C Ng
Journal:  Malays Fam Physician       Date:  2020-11-10

3.  Cryosurgery of Periocular Moderately Aggressive Basal Cell Carcinoma.

Authors:  Oscar Finskas; Oscar Zaar; Karin Svedberg
Journal:  Acta Derm Venereol       Date:  2020-11-26       Impact factor: 3.875

4.  Imiquimod does not elicit inflammatory responses in the skin of the naked mole rat (Heterocephalus glaber).

Authors:  Mosiany Letura Kisipan; Rodi Omondi Ojoo; Titus I Kanui; Klas S P Abelson
Journal:  BMC Res Notes       Date:  2020-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.